Cloned (Comment) | Organism |
---|---|
gene GALE, real-time quantitative PCR expression analysis in chondrocytes | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | silencing gene GALE with specific siRNAs in human chondrocytes | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP-glucose | Homo sapiens | - |
UDP-galactose | - |
r | |
UDP-N-acetyl-alpha-D-glucosamine | Homo sapiens | - |
UDP-N-acetyl-alpha-D-galactosamine | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q14376 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cartilage | from the knee joints | Homo sapiens | - |
chondrocyte | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
UDP-glucose | - |
Homo sapiens | UDP-galactose | - |
r | |
UDP-N-acetyl-alpha-D-glucosamine | - |
Homo sapiens | UDP-N-acetyl-alpha-D-galactosamine | - |
r |
Synonyms | Comment | Organism |
---|---|---|
Galactowaldenase | - |
Homo sapiens |
GalE | - |
Homo sapiens |
More | cf. EC 5.1.3.2 | Homo sapiens |
UDP-galactose-4-epimerase | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | GALE mRNA expression is stimulated by interleukin-1beta in early phase, but suppressed in late phase, while the suppression of GALE expression induced by interleukin-1beta is mainly mediated by stress-activated protein kinase/c-Jun N-terminal kinase pathway. Both SAP/JNK inhibitor SP600125 and p38 MAPK inhibitor SB203580 attenuate the suppression of interleukin-1beta on GAG synthesis and GALE mRNA expression of chondrocyte | down |
Homo sapiens | GALE mRNA expression is stimulated by interleukin-1beta in early phase, but suppressed in late phase, while the suppression of GALE expression induced by interleukin-1beta is mainly mediated by stress-activated protein kinase/c-Jun N-terminal kinase pathway | up |
General Information | Comment | Organism |
---|---|---|
malfunction | silencing GALE gene with specific siRNAs results in a markedly inhibition of proteoglycans (PGs)synthesis in human articular chondrocytes. GALE protein levels are also decreased in both human osteoarthritis cartilage, thus leading to losses of PGs contents. GALE inhibition might contribute to osteoarthritis progress. Mutations of gene GALE in humans results in an inherited metabolic disease, the type III galactosemia | Homo sapiens |
physiological function | UDP-galactose-4-epimerase (GALE) is a key enzyme catalyzing the interconversion of UDP-glucose and UDP-galactose, as well as UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine, which are all precursors for the proteoglycans (PGs) synthesis. Role of GALE in PGs synthesis of human articular chondrocytes, the GALE expression in osteoarthritis, and the regulation of GALE expression by interleukin-1beta, overview. GALE mRNA expression is stimulated by interleukin-1beta in early phase, but suppressed in late phase, while the suppression of GALE expression induced by interleukin-1beta is mainly mediated by stress-activated protein kinase/c-Jun N-terminal kinase pathway. Both SAP/JNK inhibitor SP600125 and p38 MAPK inhibitor SB203580 attenuate the suppression of interleukin-1beta on GAG synthesis and GALE mRNA expression of chondrocyte. Critical role of GALE in maintaining cartilage homeostasis | Homo sapiens |